Informative video by Sartorius Stedim BioOutsource on the challenges presented by ADCC when making a biosimilar.

1. Is ADCC the biggest challenge to your
biosimilar?

2. Introduction
Sartorius Stedim Biotech (SSB) BioOutsource released a new video, that is now available
on-line explaining how to overcome the issues associated with using antibody-
dependent cell-mediated cytotoxicity (ADCC) assays. The bite-sized video outlines the
factors affecting the use of ADCC assays and discusses what to consider when
determining comparability and designing biosimilar drugs.
In just five minutes, bioassay development experts, Dr. Catriona Thomson and Dr. Daniel
Galbraith describe in this engaging video the challenges of using ADCC assays and explain
when to use the different types of assay to assess biosimilars.
To watch the video please proceed to the next slide.
2

3. Any Questions?
Contact us (By Phone):
Sartorius Stedim BioOutsource Limited
1 Technology Terrace,
Todd Campus,
West of Scotland Science Park,
Glasgow, G20 0XA.
Reception: +44 (0)141 946 4222
Sales: +44 (0)141 948 1291
Contact us (By Web):
http://www.biooutsource.com/contact-us/
3